Moderna’s COVID-19 vaccine achieves over 90% efficacy in Phase III trial
January 4, 2021Sales and Marketing COVID-19, Moderna
Moderna’s COVID-19 vaccine has achieved over 90% efficacy in interim safety and primary efficacy results following its Phase III trial. …
RedHill announces positive top-line data for COVID-19 pneumonia drug
January 4, 2021Sales and Marketing COVID-19
RedHill Biopharma has announced that preliminary top-line data from its US Phase II study with orally-administered opaganib (Yeliva) in patients …
UK becomes first country to roll out Oxford University-AstraZeneca COVID-19 vaccine
January 4, 2021Sales and Marketing AstraZeneca, COVID-19, Vaccine
The UK has become the first country to administer the Oxford University-AstraZeneca COVID-19 vaccine to its population as coronavirus case …
Pharmafile.com’s top 10 stories of 2020
December 23, 2020Research and Development
The COVID-19 pandemic has, unsurprisingly, dominated the news this year. The site’s most popular articles of 2020, focused largely on …
BioInvent receives $3m payment for antibodies selected by Pfizer
December 23, 2020Research and Development BioInvent, Cancer, Pfizer
BioInvent International, a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, …
Zogenix gets EU marketing authorisation for anti-seizure drug
December 23, 2020Research and Development
The European Commission (EC) has granted marketing authorisation for Zogenix’s FINTEPLA (fenfluramine), an oral solution for the treatment of seizures …
Pharmafile.com’s weekly COVID-19 news round-up
December 23, 2020Research and Development COVID-19, Vaccine
The United States’ mission to inoculate its population is well underway this week; not only has the FDA given emergency …
Vicore Pharma study suggests C21 could complement COVID-19 vaccines
December 23, 2020Research and Development COVID-19, Vicore Pharma
Vicore Pharma, a Swedish company focused on developing medicines for severe lung disorders, has published data suggesting that its oral …
Novavax appoints Rick Crowley as Executive Vice President, Chief Operations Officer.
December 22, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Novavax, a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, has announced the appointment of Rick Crowley to …
Polyphor granted Clinical Trial Authorisation for inhaled antibiotic
December 22, 2020Manufacturing and Production Polyphor, cystic fibrosis
Polyphor, a Swiss clinical-stage biopharmaceutical company, has announced that the MHRA has granted a Clinical Trial Authorisation (CTA) to begin …
Pfizer and Moderna test COVID-19 vaccines against new strain
December 22, 2020Manufacturing and Production COVID-19, Moderna, Pfizer, Vaccine
Pfizer and Moderna have begun testing their COVID-19 vaccines against the new, fast-spreading strain of the virus that was recently …
Genentech announces positive Phase III results for faricimab
December 22, 2020Manufacturing and Production
Genentech, a member of the Roche group, today announced positive top-line results from two identically designed global Phase III studies …
Kobayashi Kako under inspection over contaminated medicines
December 22, 2020Manufacturing and Production Kobayashi Kako, rilmazafone
Japanese pharmaceutical firm Kobayashi Kako is under inspection by authorities after it emerged that the company adopted illegal manufacturing procedures …
EU gives green light to Pfizer-BioNTech COVID-19 vaccine
December 22, 2020Manufacturing and Production COVID-19, EMA, Pfizer, Vaccine
The EMA has recommended the Pfizer-BioNTech COVID-19 vaccine for use across the EU’s 27 countries, with the first doses set …
The importance of ethics and patient centricity in managed and early access programmes
December 21, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Matt Fellows explores how early and managed access schemes are mutually beneficial to sponsors and patients alike, as well as how …
4BIO Capital appoints Akiko Iwasaki to its Scientific Advisory Board
December 21, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
4BIO Capital, an international venture capital firm focused on advanced therapies addressing high unmet medical and social needs, has appointed …
Shionogi’s novel antibiotic selected for UK pilot subscription reimbursement model
December 21, 2020Sales and Marketing NICE, Shionogi, antibiotic
Japanese pharmaceutical company Shionogi today announced that NICE and NHS England and Improvement (NHSE&I) have selected its novel antibiotic Fetcroja …
European Commission approves EU’s first peanut allergy treatment
December 21, 2020Sales and Marketing Aimmune, European Commission, allergy
Aimmune Therapeutics today announced that the European Commission (EC) has approved PALFORZIA as the EU’s first-ever treatment of peanut allergy. …
AstraZeneca’s cancer drug Tagrisso gets FDA approval
December 21, 2020Sales and Marketing AstraZeneca, Cancer, FDA
The FDA has approved AstraZeneca’s Tagrisso (osimertinib) for the adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated …
Moderna’s COVID-19 vaccine receives emergency approval from FDA
December 21, 2020Sales and Marketing COVID-19, FDA, Moderna, US, Vaccine
Moderna has announced that the FDA yesterday authorised the emergency use of mRNA-1273, the biotechnology company’s vaccine against COVID-19 in …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
